France Biotech speaks out against Le Pen's protectionism

4 May 2017
2019_biotech_test_vial_discovery_big

A trade group representing France’s biotech industry has issued a warning about the protectionist policies proposed by one of the candidates standing in Sunday’s French presidential election.

Far-right candidate Marine Le Pen is hoping to defy the polls by beating centrist Emmanuel Macron of En Marche! in the vote after the two made it through the first round of voting last month.

Although Ms Le Pen has stepped down as leader of the hardline Front National (FN) party in an attempt to unite voters, this is only a temporary stance and her campaign continues to prioritize the perceived national interest of France with policies such as imposing tighter controls on national borders and immigration and a potential ‘Frexit’ and return to the French franc currency.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Biotechnology